Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal-Reference-Cited by-同舟云学术

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal

Published:2014-01-02 Issue:2 Volume:124 Page:553-563
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Zhou Bing,Damrauer Jeffrey S.,Bailey Sean T.,Hadzic Tanja,Jeong Youngtae,Clark Kelly,Fan Cheng,Murphy Laura,Lee Cleo Y.,Troester Melissa A.,Miller C. Ryan,Jin Jian,Darr David,Perou Charles M.,Levine Ross L.,Diehn Maximilian,Kim William Y.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway

2. The erythropoietin receptor in normal and cancer tissues

3. Failure to prolyl hydroxylate hypoxia-inducible factor α phenocopies VHL inactivation in vivo

4. Acute postnatal ablation of Hif-2 results in anemia

5. HIF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells: Signaling pathways and therapeutic targeting;MedComm – Oncology;2023-12

2. Therapeutic Approaches Targeting Cancer Stem Cells;Possibilities and Limitations in Current Translational Stem Cell Research;2023-06-21

3. Perivascular localized cells commit erythropoiesis in PDGF‐B‐expressing solid tumors;Cancer Communications;2023-04-29

4. Hypoxia-responsive nanomaterials for tumor imaging and therapy;Frontiers in Oncology;2022-12-15

5. Effect of erythropoiesis-stimulating agents on breast cancer patients: a meta-analysis;Clinical and Experimental Medicine;2022-10-31